InventisBio Co (SHSE:688382) Change In Payables And Accrued Expense : ¥0.0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2022. Start your Free Trial

What is InventisBio Co Change In Payables And Accrued Expense?

InventisBio Co's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2025 was ¥0.0 Mil. It means InventisBio Co's Accounts Payable & Accrued Expense stayed the same from Dec. 2024 to Mar. 2025 .

InventisBio Co's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2024 was ¥0.0 Mil. It means InventisBio Co's Accounts Payable & Accrued Expense stayed the same from Dec. 2023 to Dec. 2024 .

InventisBio Co Change In Payables And Accrued Expense Historical Data

The historical data trend for InventisBio Co's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InventisBio Co Change In Payables And Accrued Expense Chart

InventisBio Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

InventisBio Co Quarterly Data
	Dec18	Dec19	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-	-	-	-	-

InventisBio Co Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.0 Mil.

InventisBio Co Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of InventisBio Co's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

InventisBio Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InventisBio Co Ltd (SHSE:688382) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 4, Lane 67, Li Bing Road, Room 210, Pilot Free Trade Zone, Shanghai, CHN, 201203

Website

http://www.inventisbio.com

InventisBio Co Ltd is an innovative drug research and development enterprise based in China with a global perspective, focusing on major diseases such as tumors and metabolic diseases. It has independently developed a series of innovative targeted drugs with patent protection, covering non-small cell lung cancer, breast cancer, colorectal cancer and other solid tumors, as well as hyperuricemia and metabolic diseases such as gout.

InventisBio Co Headlines

No Headlines